Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccines
Data on vaccines discussed by researchers at R.E. Kavetsky Institute of Experimental Pathology
March 18th, 2008
A report, 'Antitumor efficacy of autovaccines prepared from chemoresistant tumor cells with the use of lectin OF B. subtilis B-7025,' is newly published data in Experimental Oncology. Researchers in Kiev, Ukraine conducted a study "To study whether immunogenecity of tumor cells may be altered upon the development of cytostatic drug resistance and what is the efficacy of vaccines prepared from such tumor cells." "Using immunological methods, the influence of vaccines prepared from Lewis lung carcinoma (LLC) cells, sensitive or resistant to cisplatin, with the use of cytotoxic lectins of B. subtilis B-7025 on the course of tumor development and the main effector...
Source: Cancer Weekly (2008-03-18)
|
